|
|
Volumn 108, Issue 11, 2003, Pages 1316-1323
|
|
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial
a,k
|
|
Author keywords
Angioplasty; Myocardial infarction; Platelets; Stents
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
HEPARIN;
TICLOPIDINE;
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN RECEPTOR;
IMMUNOGLOBULIN F(AB) FRAGMENT;
MONOCLONAL ANTIBODY;
ACUTE HEART INFARCTION;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLEEDING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY STENT;
CROSSOVER PROCEDURE;
DEVICE;
DRUG EFFICACY;
DRUG SAFETY;
FACTORIAL ANALYSIS;
FEMALE;
FOLLOW UP;
HEART REINFARCTION;
HOSPITAL DISCHARGE;
HUMAN;
INTERMETHOD COMPARISON;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
REVASCULARIZATION;
RISK ASSESSMENT;
STATISTICAL SIGNIFICANCE;
STROKE;
SURVIVAL;
TARGET VESSEL REVASCULARIZATION;
THROMBOCYTOPENIA;
THROMBOSIS;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
BIOASSAY;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
HEART INFARCTION;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
STENT;
ADULT;
AGED;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTIBODIES, MONOCLONAL;
COMBINED MODALITY THERAPY;
CORONARY ANGIOGRAPHY;
ENDPOINT DETERMINATION;
FEMALE;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
STENTS;
TREATMENT OUTCOME;
|
|
EID: 0141765874
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000087601.45803.86 Document Type: Article |
|
Times cited : (143)
|
|
References (9)
|
